Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Sterile protection of monkeys against malaria after administration of interleukin-12

Abstract

An estimated 300–500 million new infections and 1.5–2.7 million deaths attributed to malaria occur annually in the developing world1, and every year tens of millions of travelers from countries where malaria is not transmitted visit countries with malaria. Because the parasites that cause malaria have developed resistance to many antimalarial drugs, new methods for prevention are required. Intraperitoneal injection into mice of one dose of 150 ng (approximately 7.5 μg per kg body weight) recombinant mouse interleukin-12 (rmlL-12) 2 days before challenge with Plasmodium yoelii sporozoites protects 100% of mice against malaria2. We report that one subcutaneous injection of 10 μg/kg recombinant human IL-12 (rhIL-12) 2 days before challenge with P. cynomolgi sporozoites protected seven of seven rhesus monkeys. Protection was associated with marked increases in plasma levels of interferon-γ (IFN-γ), and relative increases of lymphoid cell messenger RNA coding for IFIM-γ and several other cytokines. We speculate that rIL-12 protects monkeys through IFN-γ-dependent elimination of P. cynomolgi-infected hepatocytes. This first report of rIL-12-induced protection of primates against an infectious agent supports assessment of rhIL-12 for immunoprophylaxis of human malaria.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. World Health Organization. Malaria. WHO Fact Sheet 94, 1–3 (1995).

  2. Sedegah, M., Finkelman, F. & Hoffman, S.L. Interleukin-12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91, 10700–10702 (1994).

    Article  CAS  Google Scholar 

  3. Schmidt, L.H., Fradkin, R., Genther, C.S., Rossan, R.N. & Squires, W. Plasmodium cynomolgi infections in the rhesus monkey. II. Responses of sporozoite-induced infections to antimalarial drugs. Am. J. Trap. Med. Hyg. 31 (Suppl.), 646–665 (1982).

    Article  CAS  Google Scholar 

  4. Nadeau, R.R., Ostrowski, C., Ni-Wu, G. & Liberate, D.J. Pharmacokinetics and pharmacodynamics of recombinant human interleukin-12 in male rhesus monkeys. J. Pharmacol. Exp. Ther. 274, 78–83 (1995).

    CAS  PubMed  Google Scholar 

  5. Villinger, F. et al. Qualitative and quantitative studies of cytokines synthesized and secreted by non-human primate peripheral blood mononuclear Cells. Cytokine 5, 469–479 (1993).

    Article  CAS  Google Scholar 

  6. Villinger, F., Brar, S.S., Mayne, A., Chikkala, N. & Ansari, A.A. Comparative sequence analysis of cytokine genes from human and nonhuman primates. J. Immunol. 155, 3946–3954 (1995).

    CAS  PubMed  Google Scholar 

  7. Gately, M.K. & Mulqueen, M.J., Interleukin-12:Potential clinical applications in the treatment and prevention of infectious diseases. Drugs 52 (Suppl. 2), 18–26 (1996).

    Article  CAS  Google Scholar 

  8. Mellouk, S., Green, S.J., Nacy, C.A. & Hoffman, S.L. IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-argininedependent effector mechanism. J. Immunol. 146, 3971–3976 (1991).

    CAS  PubMed  Google Scholar 

  9. Mellouk, S. et al. Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: Enhancement by exogenous tetrahydrobiopterin. Infect. Immun. 62, 4043–4046 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Maheshwari, R.K. et al. Recombinant human gamma interferon inhibits simian malaria. Infect. Immun. 53, 628–630 (1986).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Maheshwari, R.K. The role of cytokines in malaria infection. Bull. World Health Organ. 68 (Suppl.), 138–144 (1990).

    PubMed  PubMed Central  Google Scholar 

  12. Stevenson, M.M., Tarn, M.F., Wolf, S.F. & Sher, A. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155, 2545–2556 (1995).

    CAS  PubMed  Google Scholar 

  13. Morris, S.C. et al. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152, 1047–1056 (1994).

    CAS  PubMed  Google Scholar 

  14. Wynn, T.A., Eltoum, I., Oswald, I.P., Cheever, A.W. & Sher, A. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against eg pathology. J. Exp. Med. 179, 1551–1561 (1994).

    Article  CAS  Google Scholar 

  15. Wynn, T.A., Jankovic, D., Hieny, S., Cheever, A.W. & Sher, A. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154, 4701–1709 (1995).

    CAS  PubMed  Google Scholar 

  16. D'Andrea, A. et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer Cell stimulatory factor/IL-12 synthesis in accessory Cells. J. Exp. Med. 178, 1041–1048 (1993).

    Article  CAS  Google Scholar 

  17. Trinchieri, G. lnterleukin-12: A cytokine produced by antigen-presenting Cells with immunoregulatory functions in the generation of T-helper Cells type 1 and cytotoxic lymphocytes. Blood 84, 4008–4027 (1994).

    CAS  PubMed  Google Scholar 

  18. Ling, P. et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154, 116–127 (1995).

    CAS  PubMed  Google Scholar 

  19. Wu, C.Y. et al. In vitro maturation of human neonatal CD4+ T lymphocytes. I. Induction of IL-4-producing Cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12. J. Immunol. 152, 1141–1153 (1994).

    CAS  PubMed  Google Scholar 

  20. Malhotra, K., Salmon, D., Le Bras, J. & Vilde, J.L. Susceptibility of Plasmodium falciparum to a peroxidase-mediated oxygen-dependent microbicidal system. Infect. Immun. 56, 3305–3309 (1988).

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Sarmiento, U.M. et al. Biologic effects of recombinant human interleukin-12 in squirrel monkeys (Sciureus saimiri). Lab. Invest. 71, 862–873 (1994).

    CAS  PubMed  Google Scholar 

  22. Puri, S.K., Maheshwari, R.K., Dutta, G.P., Friedman, R.M. & Dhar, M.M. Human interferon-gamma protects rhesus monkeys against sporozoite-induced Plasmodium cynomolgi malaria infection. J. Interferon. Res. 8, 201–206 (1988).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoffman, S., Crutcher, J., Puri, S. et al. Sterile protection of monkeys against malaria after administration of interleukin-12. Nat Med 3, 80–83 (1997). https://doi.org/10.1038/nm0197-80

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0197-80

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing